PACTR202201750782433尚未招募4 期
Efficacy And Safety of Levamisole in African Children With Idiopathic Frequent Relapsing And Steroid Dependent Nephrotic Syndrome: A Protocol For A Double-Blinded, Standard of Care-Controlled Randomized Trial (ESOLAC TRIAL)
The Molecular Pathology Institute0 个研究点目标入组 72 人开始时间: 2022年1月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •1.Children between the ages of 2 and 18 years as at the last birthday
- •2.Children with Steroid sensitive Nephrotic syndrome
- •3.Children with Idiopathic Nephrotic Syndrome
- •4.Children whose caregivers signed Informed consent for their participation in the study
排除标准
- •1.Children with congenital anomaly of the urogenital system
- •2.Children with steroid-resistant nephrotic syndrome
- •3.Children who are receiving other immunosuppressive drugs
- •4.Children with End-Stage Renal Disease.
- •5.Children with Co-morbid conditions OR Systemic disease
研究者
相似试验
招募中
2 期
Evaluation of Levamisole efficacy in treatment of Covid-19IRCT20190810044500N7Yazd University of Medical Sciences50
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
进行中（未招募）
1 期
AEUCTR2016-002324-92-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)156
招募中
2 期
efficacy evaluation of livergol in children with attention deficit hyperactivity disorderattention deficit hyperactivity disorder.Attention-deficit hyperactivity disordersIRCT20160813029327N22Islamic Azad University40
已完成
不适用
Pharmacokinetics of Levosimendan in Children with Acute Heart FailureNL-OMON37072eids Universitair Medisch Centrum36